Literature DB >> 24134487

In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.

Gülgün Yenişehirli1, Ebru Tunçoğlu, Aydan Yenişehirli, Yunus Bulut.   

Abstract

BACKGROUND: In this study, we aimed to establish the in vitro antifungal susceptibilities of terbinafine, miconazole, itraconazole, ketoconazole, griseofulvin, and amphotericin B against dermatophyte isolates.
METHODS: One hundred and seventy-seven clinical isolates were tested: Trichophyton rubrum (n = 78), Trichophyton mentagrophytes (n = 49), Epidermophyton floccosum (n = 30), Trichophyton verrucosum (n = 16), and Trichophyton tonsurans (n = 4). The broth microdilution assay for antifungal susceptibility testing of dermatophytes was performed according to Clinical and Laboratory Standards Institute guidelines in the M38-A2 document.
RESULTS: Our minimum inhibitory concentration (MIC) results showed that the values for terbinafine for all dermatophyte isolates were significantly lower than the values for amphotericin B, miconazole, itraconazole, ketoconazole, and griseofulvin. For T. rubrum isolates, amphotericin B was more active than miconazole, itraconazole, and ketoconazole. Among the antifungal drugs tested, griseofulvin had the highest minimum inhibitory concentration values for T. mentagrophytes isolates.
CONCLUSION: Terbinafine was found to be the most effective antifungal drug against all tested dermatophyte isolates. Griseofulvin was the less active antifungal drug against T. mentagrophytes isolates. Performing antifungal susceptibility testing is especially important for screening the development of antifungal resistance.
© 2013 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24134487     DOI: 10.1111/ijd.12100

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

1.  Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrum.

Authors:  Shuwen Deng; Chao Zhang; Seyedmojtaba Seyedmousavi; Shuang Zhu; Xin Tan; Yiyang Wen; Xin Huang; Wenzhi Lei; Zhaojing Zhou; Wenjie Fang; Shuaishuai Shen; Danqi Deng; Weihua Pan; Wanqing Liao
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

2.  In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.

Authors:  Tzar Mohd Nizam; Rabiatul Adawiyah Ag Binting; Shafika Mohd Saari; Thivyananthini Vijaya Kumar; Marianayati Muhammad; Hartini Satim; Hamidah Yusoff; Jacinta Santhanam
Journal:  Malays J Med Sci       Date:  2016-05

3.  MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.

Authors:  Dipika Shaw; Shreya Singh; Sunil Dogra; Jyothi Jayaraman; Ramesh Bhat; Saumya Panda; Arunaloke Chakrabarti; Nishat Anjum; Aruna Chowdappa; Mahantesh Nagamoti; Umesh Varshney; Hari Pankaj Vanam; Jayanthi Savio; Meryl Antony; Shivaprakash M Rudramurthy
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran.

Authors:  Saham Ansari; Mohammad T Hedayati; Kamiar Zomorodian; Keyvan Pakshir; Hamid Badali; Abdollah Rafiei; Mostafa Ravandeh; Seyedmojtaba Seyedmousavi
Journal:  Mycopathologia       Date:  2015-09-14       Impact factor: 2.574

5.  Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection.

Authors:  Ditte M L Saunte; Rasmus K Hare; Karin M Jørgensen; René Jørgensen; Mette Deleuran; Claus O Zachariae; Simon F Thomsen; Lars Bjørnskov-Halkier; Kristian Kofoed; Maiken C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

6.  Low in vitro activity of sertaconazole against clinical isolates of dermatophyte.

Authors:  Mahsa Behnam; Hossein Zarrinfar; Mohammad Javad Najafzadeh; Ali Naseri; Lida Jarahi; Monika Novak Babič
Journal:  Curr Med Mycol       Date:  2020

7.  Oral Isotretinoin Combined with Oral Terbinafine Versus Oral Terbinafine Alone to Treat Recurrent Dermatophytosis: An Open-Label Randomised Clinical Trial.

Authors:  Kaushal K Verma; Gridharan Senthilnathan; Saurabh Bhatia; Immaculata Xess; Vishal Gupta; Sada Nand Dwivedi; Kanika Sahni
Journal:  Indian Dermatol Online J       Date:  2021-11-22

8.  Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophytonmentagrophytes Type VIII Locally and Globally.

Authors:  Maria Siopi; Ioanna Efstathiou; Konstantinos Theodoropoulos; Spyros Pournaras; Joseph Meletiadis
Journal:  J Fungi (Basel)       Date:  2021-05-27

9.  Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?

Authors:  Kabir Sardana; Ravinder Kaur; Pooja Arora; Ritu Goyal; Sneha Ghunawat
Journal:  Indian Dermatol Online J       Date:  2018 Mar-Apr

10.  Antifungal Efficacy of Amphotericin B against Dermatophytes and its Relevance in Recalcitrant Dermatophytoses: A Commentary.

Authors:  Surabhi Sinha; Kabir Sardana
Journal:  Indian Dermatol Online J       Date:  2018 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.